Colin Goddard's Net Worth
$18.9 Million
Who is Colin Goddard?
Colin Goddard has an estimated net worth of $18.9 Million. This is based on reported shares across multiple companies, which include HUMAN GENOME SCIENCES INC, ENDOCYTE INC, OSI PHARMACEUTICALS INC, and OS Therapies Inc.
SEC CIK
Colin Goddard's CIK is 0001225199
Past Insider Trading and Trends
2004 was Colin Goddard's most active year for acquiring shares with 13 total transactions. Colin Goddard's most active month to acquire stocks was the month of April. 2004 was Colin Goddard's most active year for disposing of shares, totalling 132 transactions. Colin Goddard's most active month to dispose stocks was the month of May. 2010 saw Colin Goddard paying a total of $1,534,500.00 for 91,000 shares, this is the most they've acquired in one year. In 2010 Colin Goddard cashed out on 998,355 shares for a total of $53,456,632.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
HUMAN GENOME SCIENCES INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -10.73K |
$14.25 | -$152,845.50 |
0
|
Jul 30
| |||
Form 4
| +30.39% | 2.5K |
—
|
—
| 10.73K |
May 17
| |||
Form 4
| +57.41% | 3K |
$16.17 | $48,510.00 | 8.23K |
Aug 4
| |||
Form 4
| +91.71% | 2.5K |
—
|
—
| 5.23K |
May 12
| |||
Form 4
|
∞
| 2.73K |
$27.41 | $74,727.84 | 2.73K |
Mar 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ENDOCYTE INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -11.10K |
$24.00 | -$266,400.00 |
0
|
Dec 21
| |||
Form 4
| +42.31% | 3.3K |
—
|
—
| 11.1K |
May 3
| |||
Form 4
| +73.33% | 3.3K |
—
|
—
| 7.8K |
May 4
| |||
Form 4
| +100.00% | 2.25K |
—
|
—
| 4.5K |
May 5
| |||
Form 4
|
∞
| 2.25K |
—
|
—
| 2.25K |
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
OSI PHARMACEUTICALS INC No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -4.17K |
$57.50 | -$240,062.50 |
0
|
Jun 7
| |||
Form 4
| -97.36% | -154.09K |
$57.50 | -$8,860,175.00 | 4.17K |
Jun 3
| |||
Form 4
|
—
|
0
|
$39.21 | -$2,106,720.00 | 158.26K |
Scheduled
|
Mar 1
| ||
Form 4
| +25.38% | 32.03K |
$32.89 | -$97,617.52 | 158.26K |
Dec 15 - Dec 16
| |||
Form 4
| -3.06% | -3.98K |
$34.75 | -$138,305.00 | 126.23K |
Dec 12 - Dec 13
| |||
Form 4
| +0.10% | 125 |
$33.68 | $4,210.00 | 130.21K |
Dec 4
| |||
Form 4
| +23.79% | 25K |
—
|
—
| 130.09K |
Dec 16
| |||
Form 4
| -2.63% | -2.83K |
$33.39 | -$94,593.87 | 105.09K |
Dec 12 - Dec 13
| |||
Form 4
| +22.71% | 19.94K |
$47.79 | -$50,561.82 | 107.74K |
Dec 12 - Dec 13
| |||
Form 4
|
—
|
0
|
$21.93 | -$1,234,250.34 | 87.8K |
Scheduled
|
Jun 4
| ||
Form 4
| +16.64% | 12.53K |
—
|
—
| 87.8K |
Dec 13
| |||
Form 4
| -3.52% | -2.75K |
$36.32 | -$99,886.00 | 75.27K |
Scheduled
|
Aug 25
| ||
Form 4
| +3.65% | 2.75K |
$21.97 | -$746,133.12 | 78.02K |
Scheduled
|
Aug 25
| ||
Form 4
| +28.51% | 16.7K |
—
|
—
| 75.27K |
Jul 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
$19.56 | -$507,014.37 | 58.57K |
Scheduled
|
Jun 2
| ||
Form 4
| +51.85% | 20K |
$9.00 | $180,000.00 | 58.57K |
Oct 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
$29.50 | -$164,000.00 | 38.57K |
Scheduled
|
Apr 15
| ||
Form 4
|
—
|
0
|
$31.49 | -$179,930.08 | 38.57K |
Scheduled
|
Mar 1
| ||
Form 4
|
—
|
0
|
$37.06 | -$224,484.68 | 38.57K |
Scheduled
|
Feb 1
| ||
Form 4
|
—
|
0
|
$41.49 | -$259,863.55 | 38.57K |
Scheduled
|
Jan 3
| ||
Form 4
| +12.79% | 4.37K |
$45.72 | $199,979.28 | 38.57K |
Dec 8
| |||
Form 4
|
—
|
0
|
$27.60 | -$344,013.12 | 34.2K |
Scheduled
|
Dec 1
| ||
Form 4
|
—
|
0
|
$34.87 | -$492,237.18 | 34.2K |
Scheduled
|
Nov 1
| ||
Form 4
|
—
|
0
|
$33.17 | -$466,289.84 | 34.2K |
Scheduled
|
Oct 1
| ||
Form 4
|
—
|
0
|
$32.20 | -$358,407.64 | 34.2K |
Scheduled
|
Sep 1
| ||
Form 4
|
—
|
0
|
$31.71 | -$353,248.11 | 34.2K |
Scheduled
|
Aug 2
| ||
Form 4
|
—
|
0
|
$37.57 | -$431,416.32 | 34.2K |
Scheduled
|
Jul 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
$43.06 | -$508,164.66 | 34.2K |
Scheduled
|
Jun 1
| ||
Form 4
|
—
|
0
|
$38.82 | -$461,411.40 | 34.2K |
May 3
| |||
Form 4
|
—
|
0
|
$22.13 | -$238,631.25 | 34.2K |
Apr 20
| |||
Form 4
| +26.05% | 23.95K |
$16.74 | -$193,451.70 | 115.9K |
Dec 22
| |||
Form 4
|
—
|
0
|
$19.49 | -$170,625.00 | 10.25K |
Aug 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
OS Therapies Inc (OSTX) Snapshot price: $4.1799
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |